Global Gamma Delta T Cell Cancer Therapy Market & Clinical Trials Report 2024: Gamma Delta T Cell Therapy Poised to Revolutionize Cancer Treatment by 2030, Surpassing 30 Therapies in Clinical Trials
01. Juli 2024 10:17 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Global Gamma Delta T Cell Cancer Therapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...
Canadian Brain Cancer Patients Treated Unequally: Brain Cancer Canada
26. Oktober 2022 08:30 ET
|
Brain Cancer Canada
TORONTO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- For Canadians diagnosed with brain cancer, where they live determines how much access they have to treatment, according to new research by the charity...
Global PARP Inhibitors Cancer Therapy Market Outlook 2022-2028: PARP Inhibitors have Proved to be a Commercial Success in the Modern Cancer Therapeutic Segment
08. Juni 2022 04:43 ET
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's...
Surgery Treatment of Glioblastoma Multiforme to Register a Double-digit Growth in next ten years, Fact.MR
17. März 2022 11:45 ET
|
FACT.MR
ROCKVILLE, Md., March 17, 2022 (GLOBE NEWSWIRE) -- The Glioblastoma Multiforme Treatment Market revenues were estimated at US$ 2.6 Bn in 2021 and is anticipated to grow at a CAGR of 10.1% from...
Investigation Report on China's Temozolomide Market 2021-2025 Featuring Merck Sharp & Dohme, Jiangsu Tasly Diyi Pharma, Beijing Shuanglu Pharma, Schering-Plough, Jiangsu Hengrui Medicine Co
31. Dezember 2021 04:53 ET
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Temozolomide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The sales value of...
Oncotelic Reports that It's Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma
13. Februar 2019 09:15 ET
|
Oncotelic Inc
Phase 2 Clinical Data Presented at 11th AACR-JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision MedicineOT-101 exhibited promising single agent clinical activity as second...